The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Gabapentin dose and the 30-day risk of altered mental status in older adults: A retrospective population-based study
Open accessAbstract
Gabapentin is an effective treatment for chronic neuropathic pain but may cause dizziness, drowsiness, and confusion in some older adults. The goal of this study was to assess the association between gabapentin dosing and adverse outcomes by obtaining estimates of the 30-day risk of hospitalization with altered mental status and mortality in older adults (mean age 76 years) in Ontario, Canada initiated on high dose (>600 mg/day; n = 34,159) compared to low dose (≤600 mg/day; n = 76,025) oral gabapentin in routine outpatient care. A population-based, retrospective cohort study assessing new gabapentin use between 2002 to 2014 was conducted. The primary outcome was 30-day hospitalization with an urgent head computed tomography (CT) scan in the absence of evidence of stroke (a proxy for altered mental status). The secondary outcome was 30-day all-cause mortality. The baseline characteristics measured in the two dose groups were similar. Initiation of a high versus low dose of gabapentin was associated with a higher risk of hospitalization with head CT scan (1.27% vs. 1.06%, absolute risk difference 0.21%, adjusted relative risk 1.29 [95% CI 1.14 to 1.46], number needed to treat 477) but not a statistically significant higher risk of mortality (1.25% vs. 1.16%, absolute risk difference of 0.09%, adjusted relative risk of 1.01 [95% CI 0.89 to 1.14]). Overall, the risk of being hospitalized with altered mental status after initiating gabapentin remains low, but may be reduced through the judicious use of gabapentin, use of the lowest dose to control pain, and vigilance for early signs of altered mental status.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Skipping, abruptly stopping, or incorrectly taking gabapentoid doses can increase the risk of experiencing adverse symptoms [32].”
From Voice Assistant Reminders and the Latency of Scheduled Medication Use in Older Adults With Pain: Descriptive Feasibility Study (2021) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010 · Cited by 17,796
Vandenbroucke, J. P., Elm, E. V., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., Egger, M., & initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010-w1 · Cited by 3,543
Austin, P. C. (2009) · Communications in Statistics - Simulation and Computation · doi:10.1080/03610910902859574 · Cited by 2,445
Backonja, M. (1998) · JAMA · doi:10.1001/jama.280.21.1831 · Cited by 1,533
Gabapentin for chronic neuropathic pain and fibromyalgia in adults
Moore, R. A., Wiffen, P. J., Derry, S., & McQuay, H. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007938.pub2 · Cited by 690
Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study
Rice, A. S. C., & Maton, S. (2001) · Pain · doi:10.1016/s0304-3959(01)00407-9 · Cited by 596
Gabapentin: pharmacology and its use in pain management
Rose, M. A., & Kam, P. C. A. (2002) · Anaesthesia · doi:10.1046/j.0003-2409.2001.02399.x · Cited by 535
(2003) · PubMed · Cited by 490
Research works printed but not linked: 3
- TW Post, 2016, Gabapentin Drug Information., UpToDate
- E Von Elm, 2007, 147, 573
- M Backonja, 2003, 25, 81
Cited by
Saur, N. M., Davis, B. R., Montroni, I., Shahrokni, A., Rostoft, S., Russell, M. M., Mohile, S. G., Suwanabol, P. A., Lightner, A. L., Poylin, V. Y., et al. (2022) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000002410 · Cited by 100
Elucidating the Potential Side Effects of Current Anti-Seizure Drugs for Epilepsy
Akyüz, E., Köklü, B., Ozenen, C., Arulsamy, A., & Shaikh, M. F. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210826125341 · Cited by 81
“In a study examining the effects of high and low dose usage of gabapentin in the elderly, the high dose patients with a history of chronic renal failure had a higher risk of hospitalization with an altered mental state [63, 64].”
BackgroundMujukian, A., Truong, A., Tran, H. P. N., Shane, R. R., Fleshner, P. R., & Zaghiyan, K. N. (2019) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-019-04385-9 · Cited by 54
Seizures and epilepsy in patients with ischaemic stroke
Zöllner, J. P., Schmitt, F. C., Rosenow, F., Kohlhase, K. D., Seiler, A., Strzelczyk, A., & Stefan, H. (2021) · Neurological Research and Practice · doi:10.1186/s42466-021-00161-w · Cited by 49
“Of note, GBP carries the risk of dizziness, vertigo and altered mental status in elderly patients, especially with higher daily doses [35].”
BackgroundRajan, J., & Behrends, M. (2019) · Anesthesiology Clinics · doi:10.1016/j.anclin.2019.04.009 · Cited by 44
Metadata
- Authors
- Fleet, J. L., Dixon, S. N., Kuwornu, P. J., Dev, V. K., Montero-Odasso, M., Burneo, J., & Garg, A. X.
- Affiliations
- McMaster University (CA)
- Western University (CA)
- Sunnybrook Hospital (CA)
- Corresponding author
- Fleet, Jamie L.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-03-14
- Volume
- 13
- Issue
- 3
- Pages
- e0193134
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5851574
- OpenAlex
- W2793971339
- Cited by
- 60
- References
- 31
- Citations by year
- 2026: 9 · 2025: 7 · 2024: 10 · 2023: 7 · 2022: 7 · 2021: 8 · 2020: 5 · 2019: 5
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Lawson Health Research Institute
- London Health Sciences Centre
- Academic Medical Organization of Southwestern Ontario
- Institute for Clinical Evaluative Sciences
- Ontario Ministry of Health and Long-Term Care
- Canadian Institutes of Health Research
- Schulich School of Medicine and Dentistry
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- gabapentin, altered mental status, older adults, neuropathic pain, drug safety, hospitalization, all-cause mortality, adverse drug reactions, head CT
- MeSH terms
- Gabapentin, Aged, Aged, 80 and over, Amines, Confusion, Cyclohexanecarboxylic Acids, Dizziness, Female, gamma-Aminobutyric Acid, Hospitalization, Humans, Male, Neuralgia, Retrospective Studies, Risk Factors, Sleep Stages, Tomography, X-Ray Computed, Survival Rate, Disease-Free Survival
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gabapentin dose and the 30-day risk of altered mental status in older adults: A retrospective population-based study. https://app.cochat.ai/papers/10.1371/journal.pone.0193134
- The paper
- Fleet, J. L., Dixon, S. N., Kuwornu, P. J., Dev, V. K., Montero-Odasso, M., Burneo, J., & Garg, A. X. (2018). Gabapentin dose and the 30-day risk of altered mental status in older adults: A retrospective population-based study. PLOS ONE. https://doi.org/10.1371/journal.pone.0193134
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.